ArticleThe journal of obstetrics and gynaecology research2026
Factors Affecting Quality of Life of Thai Cervical Cancer Patients.
Article in The journal of obstetrics and gynaecology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThis study aimed to assess the quality of life (QoL) among Thai patients with cervical cancer and identify the factors influencing utility scores using the European Organization for the Research and Treatment of Cancer: Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), EORTC: Cervical Cancer Module 24 (EORTC QLQ-CX24), and EQ-5D-5L instruments.
methodsThis cross-sectional study was conducted at Vajira Hospital, Thailand, and included 205 patients with cervical cancer. Demographics data, cancer stage, treatment status, and caregiving support, were collected. The participants completed the QoL questionnaires. Multivariate Tobit regression analysis was used to analyze the predictors of EQ-5D-5L utility scores.
resultsThe mean global QoL score (EORTC QLQ-C30) and mean utility score (EQ-5D-5L) were 73.62 ± 21.57 and 0.90 ± 0.18, respectively. Fatigue was the most frequently reported symptom, whereas sexual dysfunction (EORTC QLQ-CX24) and emotional distress were common challenges. Patients who had completed treatment without disease reported the highest utility score (mean: 0.96), whereas Stages III-IVA patients under palliative care had the lowest utility score (mean: 0.66). Multivariable analysis revealed that Stage III/IVa, palliative treatment, and having at least one caregiver were independently associated with significantly lower utility scores.
conclusionsCervical cancer significantly affects the QoL, with advanced stage and treatment status being major contributors to reduced utility. Additionally, the patient symptom burden is dominated by prominent fatigue and a distinct sexual health profile, characterized by a marked discordance between profoundly low sexual activity and persistent sexual worry.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.